Herbalife shares see mysterious rise
The stock has been volatile in the high-stakes battle over the multi-level marketer.
Herbalife, based in the Cayman Islands, rose more than 8% at midday Monday to $43.57. The stock has surged more than 30% since the start of the year. There doesn't appear to be any news that could account for the gain, so it could be a short squeeze, which is bad news for investors such as Ackman who profit when stock prices fall.
Wall Street analysts remain bullish on Herbalife. The average 52-week price target on the stock is $62.29, more than 40% higher than where it currently trades. Sentiment on the stock, though, could easily change depending on the outcome of the SEC probe.
Ackman's campaign has had an impact. According to StreetInsider.com, Herbalife had the largest gain in short interest of any stock on the New York Stock Exchange between Dec. 14 and Dec. 21. Ackman, who has also made a huge bet that struggling retailer J.C. Penney (JCP) will rebound, remains undeterred and has said he thinks the stock's price will go to zero. A presentation his Pershing Square Capital Management firm made about Herbalife minces no words.
"Pershing Square believes Herbalife is a pyramid scheme because, among other reasons,
distributors earn more than 10 times as much from recruitment as they do by selling the
company’s overpriced products to bona fide retail customers," it says.
Another activist investor, Daniel Loeb of Third Point, has called Ackman's short thesis "preposterous" and last week disclosed that his firm, which has also made big bets on Yahoo (YHOO) and Greek bonds, owned an 8.2% stake in Herbalife.
Ackman or Loeb will either win or lose big with Herbalife. There will be no middle ground.
--Jonathan Berr doesn't own shares of the listed stocks. Follow him on Twitter @jdberr.
More on Money Now
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
More than 8,000 households got hit with the one-time levy as Socialist President Francois Hollande continues to target the nation's wealthiest.
- Farmers cultivate drones as new high-tech tool
- Apple's overseas hoard unfair to taxpayers
- Why hugely profitable ESPN is laying off workers
- Tornado shelters become a vital business
- Victoria's Secret won't sell cancer 'survivor' bras
- DC is doing nothing to fix the economy
- Models have it easier getting into US than engineers
- Bernie Madoff earns sweatshop wages in prison
- Motor home sales rise in hopeful economic sign
[BRIEFING.COM] Stocks ended modestly higher as the S&P 500 climbed 0.2%, and the Dow added 0.4% to register its 19th consecutive Tuesday of gains.
The major averages saw little change during morning action, but afternoon buying interest helped lift the indices to session highs. Most cyclical sectors (with the exception of materials and technology) finished among the leaders, but the defensively-geared health care sector settled atop the leaderboard as biotechnology outperformed. ... More
More Market News
The auto parts giant beats Wall Street expectations, while continuing to expand its stores in the U.S. and Mexico.